All recombinant DNA and infectious agent work activities, even if exempt from full Institutional Biosafety Committee (IBC) review under NIH guidelines, must be registered (granting agencies often request information on research review status from our office).
To register your biosafety related work, please contact the University's Biosafety Officer to start the process. Once approved by the IBC, your project will be authorized for a three year period.
In March, 2016, all research protocols will be managed by the Click Safety Module. This service provides support for the submission, review and reporting of protocols in the areas of Biosafety and Stem Cell Research as well as Chemical Safety and Radiation Safety oversight. It was designed to strengthen committee oversight while accelerating the preparation, submission and review of research studies.
Please note there is an additional Biosafety Level Category listed as BSL-2+. This indicates that the risk analysis of the work activity requires the physical containment and protocol requirements of BSL-2 containment with additional special practices requirements. For example, in the case of the use of a second generation Lentiviral vector used to deliver an oncogene. It would be prudent to carry out ALL work with this agent in a Biosafety Cabinet in a restricted area, accessible only by trained and appropriately garbed personnel. Click for biosafety level Information (pdf).
American Biological Safety Association:
Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition